Search research articles
Contact Us
Filters
Showing results (491-500 of 740) with videos related to
Page
of 74
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2009
Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
I Vergote, N Finkler, J del Campo, et al.
American Journal of Infection Control
|
October 7, 2008
Mortality and time to extubation in severe hospital-acquired pneumonia
Sarah M Connelly, Jane V Trinh, Melissa D Johnson, et al.
Open Forum Infectious Diseases
|
June 27, 2018
Towards a Definition for Health Care-Associated Infection
N Deborah Friedman, Dana Levit, Eyal Taleb, et al.
Cancer Research
|
December 5, 2000
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial
J Nemunaitis, I Ganly, F Khuri, et al.
The Journal of Antimicrobial Chemotherapy
|
October 7, 2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials
Myra W Popejoy, David L Paterson, Daniel Cloutier, et al.
Diagnostic Microbiology and Infectious Disease
|
August 16, 2011
Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit
Marilynn R Fairfax, Anne Marie Queenan, Paul R Lephart, et al.
American Journal of Infection Control
|
February 14, 2012
Epidemiology and outcomes associated with surgical site infection following bariatric surgery
Teena Chopra, Dror Marchaim, Ylinne Lynch, et al.
British Journal of Cancer
|
July 9, 2004
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
M Harries, C Moss, T Perren, et al.
Open Forum Infectious Diseases
|
July 21, 2021
Risk Factors for and Mechanisms of <i>CO</i>listin <i>R</i>esistance Among <i>E</i>nterobacterales: Getting at the CORE of the Issue
John P Mills, Laura J Rojas, Steve H Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 26, 2025
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis
Thomas P Lodise, Anita F Das, Niels Frimodt-Møller, et al.
Page
of 74
Search research articles
Search
Showing results (491-500 of 740) with videos related to
Sort By:
Page
of 74
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2009
Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
I Vergote, N Finkler, J del Campo, et al.
American Journal of Infection Control
|
October 7, 2008
Mortality and time to extubation in severe hospital-acquired pneumonia
Sarah M Connelly, Jane V Trinh, Melissa D Johnson, et al.
Open Forum Infectious Diseases
|
June 27, 2018
Towards a Definition for Health Care-Associated Infection
N Deborah Friedman, Dana Levit, Eyal Taleb, et al.
Cancer Research
|
December 5, 2000
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial
J Nemunaitis, I Ganly, F Khuri, et al.
The Journal of Antimicrobial Chemotherapy
|
October 7, 2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials
Myra W Popejoy, David L Paterson, Daniel Cloutier, et al.
Diagnostic Microbiology and Infectious Disease
|
August 16, 2011
Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit
Marilynn R Fairfax, Anne Marie Queenan, Paul R Lephart, et al.
American Journal of Infection Control
|
February 14, 2012
Epidemiology and outcomes associated with surgical site infection following bariatric surgery
Teena Chopra, Dror Marchaim, Ylinne Lynch, et al.
British Journal of Cancer
|
July 9, 2004
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
M Harries, C Moss, T Perren, et al.
Open Forum Infectious Diseases
|
July 21, 2021
Risk Factors for and Mechanisms of <i>CO</i>listin <i>R</i>esistance Among <i>E</i>nterobacterales: Getting at the CORE of the Issue
John P Mills, Laura J Rojas, Steve H Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 26, 2025
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis
Thomas P Lodise, Anita F Das, Niels Frimodt-Møller, et al.
Page
of 74